Erwin Jennifer A, Lee Jeannie T
Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Curr Opin Cell Biol. 2008 Jun;20(3):349-55. doi: 10.1016/j.ceb.2008.04.007. Epub 2008 May 26.
Dosage compensation, the mechanism by which organisms equalize the relative gene expression of dimorphic sex chromosomes, requires action of a diverse range of epigenetic mechanisms. The mammalian form, 'named X-chromosome inactivation' (XCI), involves silencing of one X chromosome in the female cell and regulation by genes that make noncoding RNAs (ncRNA). With large-scale genomic and transcriptome studies pointing to a crucial role for noncoding elements in organizing the epigenome, XCI emerges as a major paradigm and a focus of active research worldwide. With more surprising twists, recent advances point to the significance of RNA-directed chromatin change, chromosomal trans-interactions, nuclear organization, and evolutionary change. These findings have impacted our understanding of general gene regulation and are discussed herein.
剂量补偿是生物体使异型性染色体的相对基因表达均等化的机制,它需要多种表观遗传机制发挥作用。哺乳动物的这种形式,即“X染色体失活”(XCI),涉及雌性细胞中一条X染色体的沉默以及由产生非编码RNA(ncRNA)的基因进行调控。随着大规模基因组和转录组研究表明非编码元件在组织表观基因组中起关键作用,XCI成为一个主要范例和全球积极研究的焦点。更令人惊讶的是,最近的进展表明了RNA导向的染色质变化、染色体反式相互作用、核组织和进化变化的重要性。这些发现影响了我们对一般基因调控的理解,本文将对此进行讨论。